Sanofi Says FDA Extends Review Target Date For Tolebrutinib

Sanofi SA SAN:

• FDA EXTENDS REVIEW TARGET DATE FOR TOLEBRUTINIB

• FDA DECISION DATE FOR TOLEBRUTINIB SET FOR DECEMBER 28, 2025

• FDA CONSIDERS ADDITIONAL ANALYSES A MAJOR AMENDMENT TO NDA